ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
0.6606
+0.0455 (7.40%)
At close: Aug 13, 2025, 4:00 PM
0.6640
+0.0034 (0.51%)
Pre-market: Aug 14, 2025, 8:02 AM EDT
ALX Oncology Holdings Market Cap
ALX Oncology Holdings has a market cap or net worth of $35.31 million as of August 14, 2025. Its market cap has decreased by -88.42% in one year.
Market Cap
35.31M
Enterprise Value
-27.83M
1-Year Change
-88.42%
Ranking
Category
Stock Price
$0.66
Market Cap Chart
Since July 17, 2020, ALX Oncology Holdings's market cap has decreased from $1.06B to $35.31M, a decrease of -96.66%. That is a compound annual growth rate of -48.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 35.31M | -59.92% |
| Dec 31, 2024 | 88.08M | -88.13% |
| Dec 29, 2023 | 741.80M | 61.50% |
| Dec 30, 2022 | 459.31M | -47.23% |
| Dec 31, 2021 | 870.34M | -74.66% |
| Dec 31, 2020 | 3.43B | 225.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |